San Diego-centered Viking Therapeutics marked alone as a serious competitor from the weight loss drug market in February immediately after revealing promising info from a mid-stage demo of experimental drug VK2735, which instructed it rivaled—and outperformed—Novo and Lilly drugs when supplied to be a weekly injection and in March the company u